Protara Therapeutics Inc (TARA)
Protara Therapeutics Market Cap: 63.62M for May 17, 2024
Market Cap Chart
Historical Market Cap Data
Date | Value |
---|---|
May 17, 2024 | 63.62M |
May 16, 2024 | 77.01M |
May 15, 2024 | 76.39M |
May 14, 2024 | 68.77M |
May 13, 2024 | 66.71M |
May 10, 2024 | 61.77M |
May 09, 2024 | 61.36M |
May 08, 2024 | 58.27M |
May 07, 2024 | 59.09M |
May 06, 2024 | 59.71M |
May 03, 2024 | 59.92M |
May 02, 2024 | 59.51M |
May 01, 2024 | 60.33M |
April 30, 2024 | 61.36M |
April 29, 2024 | 63.79M |
April 26, 2024 | 60.19M |
April 25, 2024 | 62.76M |
April 24, 2024 | 58.03M |
April 23, 2024 | 61.74M |
April 22, 2024 | 62.76M |
April 19, 2024 | 54.33M |
April 18, 2024 | 56.59M |
April 17, 2024 | 56.18M |
April 16, 2024 | 58.65M |
April 15, 2024 | 58.44M |
Date | Value |
---|---|
April 12, 2024 | 61.74M |
April 11, 2024 | 63.59M |
April 10, 2024 | 65.64M |
April 09, 2024 | 36.82M |
April 08, 2024 | 39.22M |
April 05, 2024 | 41.50M |
April 04, 2024 | 45.96M |
April 03, 2024 | 46.88M |
April 02, 2024 | 46.99M |
April 01, 2024 | 47.34M |
March 28, 2024 | 45.85M |
March 27, 2024 | 45.74M |
March 26, 2024 | 47.45M |
March 25, 2024 | 45.62M |
March 22, 2024 | 45.96M |
March 21, 2024 | 44.59M |
March 20, 2024 | 46.08M |
March 19, 2024 | 45.74M |
March 18, 2024 | 45.74M |
March 15, 2024 | 42.08M |
March 14, 2024 | 40.82M |
March 13, 2024 | 41.73M |
March 12, 2024 | 40.82M |
March 11, 2024 | 40.82M |
March 08, 2024 | 43.45M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
AngioDynamics Inc | 241.93M |
Regulus Therapeutics Inc | 130.93M |
Bio-Path Holdings Inc | 1.453M |
Outset Medical Inc | 186.72M |
NovaBay Pharmaceuticals Inc | 4.487M |
Market Cap Related Metrics
Price to Book Value | 1.089 |
Price | 3.10 |
Earnings Yield | -121.0% |